epidemiology Flashcards

1
Q

case fatality rate - what is it?

A

proportion of people w/a condition than end up dying from the condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is case fatality rate different from mortality rate?

A

mortality has a denominator of entire population (even those w/o the condition) so is generally smaller than CFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

attack rate - what is it?

A

proportion of pl who develop an illness out of total population at risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

median survival time - what is it?

A

length of time it takes for 1/2 study population to die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

standardized mortality ratios - what are they?

A

used to determine if the observed number of deaths in a group exceeds what would expect in a similar group (age, gender) excluding the variable of interest (smoking, cholesterol status)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SnNout - what does this mean?

A

in sensitive test, negative result helps rule OUT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SpPin - what does this mean?

A

in specific test, positive helps rule IN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PPV - equation?

A

TP / (TP + FP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PPV - what does it mean?

A

probability that a positive test correctly identifies person w/dz (usually correlates best with highest SPECIFICITY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

does PPV depend on prevalence?

A

YES, increases with increasing prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NPV - what does it mean?

A

probability that a negative test correctly identifies someone w/o the dz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NPV - equation?

A

TN/(TN +FN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

absolute risk reduction (ARR) - how calculate?

A

subtract risk of relapses in treatment group from placebo group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

number needed to treat - how calculate?

A

1/ARR (absolute risk reduction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

odds ratio - how calculate?

A

probability divided by (1 minus probability) P/(1-P)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

odds ratio - how calculate w/ 2x2 plot?

A

(a/c)/(b/d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

RR (relative risk) - what is it?

A

a ratio obtained by dividing 2 values (can divide 2 RRs to get cumulative RR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

if the RR of an outcome in group A as compared to B is x, what is the RR in group B as compared to group A?

A

1/x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

likelihood ratio - what is it?

A

probability of a given test result occurring in a pt w/a disorder compared to the probability of same result in pt w/o the d/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

positive LR - equation?

A

sensitivity / (1-specificity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

negative LR

A

(1-sensitivity) / specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

are sensitivity and specificity independent or dependent on disease prevalence?

A

independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

what can you use to calculate post-test odds?

A

LR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

post-test odds - equation?

A

= pre-test odds * LR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
which test can be used to compare the results of multiple diagnostic tests?
LR
26
factorial study design - what is it?
study that uses >= 2 interventions and all combinations of these interventions (ie A, B, A and B, or nothing)
27
crossover study - what is it?
study where patients are exposed to different treatments/exposures sequentially
28
nested study - what is it?
retrospective observational study where subsets of controls are matched to cases and analyzed for variables of interest
29
is case-control study prospective or retrospective?
retrospective
30
primordial prevention
prevention of risk factors themselves
31
primary prevention
prevention of complications from a risk factor (ie someone with hld, start statin to prevnt MI)
32
secondary prevention
attempts to halt dz rogression beore irreversible changes take place
33
tertiary prevention
disease progressed beyond early stages, trying to limit impairments and disabilities (ie CABG)
34
quaternary prevention
ie preventing unnecessary repeat cardiac cath by using shared med record
35
sensitivity analysis
repeating primary analysis calculations after modifying variable ranges to see if modifications significantly affect results initialy obtained
36
propensity scoring
weighs different variables (ie severity of different comorbidities) in tx and control groups to ensure variables are balanced between both groups
37
lead time bias
happens when a test diagnoses a dz earlier than another test so "apparent survival period" appears longer
38
length time bias
subjects with rapidly progressive dz are less likely to be detected by screening compared to those w/slowly progressive dz
39
informed consent applies to which ethical principle of medicine?
autonomy
40
fairness in deciding who gets scarce resources applies to which ethica principle of medicine?
justice
41
not taking actions with respect to a patient that may be harmful or doubtful benefit - which medical ethical principle?
nonmaleficence
42
needed to harm (NNH)
inverse of the absolute risk increase (difference in incidence rate between exposed and non-exposed groups)
43
needed to treat (NNT)
inverse of the absolute risk reduction (difference in incidence rate between exposed and non-exposed groups)
44
net clinical benefit
possible benefit minus possible harm
45
intention to treat analysis - what is the main intent?
maintain randomization (ie avoid effects of crossover and dropout)
46
observer bias
observer may be influenced by prior knowledge or details of the study that affect the results
47
what do you do to avoid observer bias?
blinding
48
type II error
failure to reject the null hypothesis when it is false
49
why does type II error happen?
need good power of study (depends on sample size)
50
ppv calculation
TP / (TP + FP)
51
false positive rate
FP / (FP + TN)
52
NPV
TN / (TN + FN)
53
sensitivity calculation
TP / (TP + FN)
54
specificity
TN / (TN + FP)
55
PPV
TP / (TP + FP)
56
NPV
TN / (TN + FN)
57
positive LR
sensitivity / (1 - specificity)
58
negative LR
(1-sensitivity) / specificity
59
specificity - definition in words
probability of a nondiseased person testing negative
60
sensitivity - definition in words
probability of a diseased person testing positive
61
criteria for lung ca screening?
- age 55-80 - 30+ pack years - quit less than 15 years ago or current smoker
62
attributable risk percentage - calculation?
(risk in exposed - risk in unexposed) / risk in exposed OR (RR-1)/RR
63
population attributable risk percent - how different than attributable risk percentage?
PARP = measure of excess risk in the total population, not just those exposed
64
population attributable risk percent - equation?
(risk in total population - risk in unexposed) / risk in total population
65
risk in total population - equation?
(risk in exposed)(proportion exposed) + (risk in nonsmokers)(proportion of nonsmokers)
66
type II error
study fails to reject a null hypothesis that is false (false negative)
67
equation for power
power = 1-B
68
type I error
study rejects null hypothesis that is true (false positive)
69
standardized mortality ratio - calculation?
observed # of deaths in pop of interest / expected # of deaths in total pop
70
negatively skewed distribution?
mean < median < mode (mea, med, mo)
71
positively skewed distribution?
mode < median < mean (mo, med, mea)
72
in skewed distributions, what is most valid measure of central location?
median
73
what is internal validity?
are we measuring what we think we are measuring
74
what is the major threat to internal validiy?
confounding
75
LR+
probability of pt w/dz testing positive divided by the probability of a pt without the disease testing positive
76
LR-
probability of a pt with the dz testing negative divided by the proability of a pt without the disease testing negative
77
NNT - equation?
``` NNT = 1/ARR ((ARR = control rate - treatment rate)) ```
78
absolute risk reduction (ARR) - equation?
ARR = control rate = treatment rate